Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment

As a nontraditional T-cell subgroup, γδT cells have gained popularity in the field of immunotherapy in recent years. They have extraordinary antitumor potential and prospects for clinical application. Immune checkpoint inhibitors (ICIs), which are efficacious in tumor patients, have become pioneer d...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Zhifei, Bai, Yifeng, Lin, Anqi, Jiang, Aimin, Zhou, Chaozheng, Cheng, Quan, Liu, Zaoqu, Chen, Xin, Zhang, Jian, Luo, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930367/
https://www.ncbi.nlm.nih.gov/pubmed/36793048
http://dx.doi.org/10.1186/s12943-023-01722-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930367/
https://www.ncbi.nlm.nih.gov/pubmed/36793048
http://dx.doi.org/10.1186/s12943-023-01722-0

Ejemplares similares